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Introduction
About 635,000 new cases of coronary heart disease (CHD) occur annually in the United States, with an additional 155,000 incidentally discovered asymptomatic silent MIs (SMI). 1 SMI, defined as the presence of pathological Q waves in the absence of a history of typical cardiac symptoms, is one of the important cardiac abnormalities that can be reasonably detected through electrocardiogram (ECG) screening. 2, 3 Given that SMI is characterized by no or mild symptoms, those patients are deprived from medical treatments that could prevent subsequent adverse outcomes, including a second MI or even death. 4 This underscores the importance of detection of SMI in clinical practice. In clinical trials evaluating interventions to prevent or treat CHD, detection of unrecognized MI as a clinical end point has the potential to increase statistical power and allowing decreased sample sizes or reduced length of follow-up, cost, and potential harm from exposure. 4 The reported incidence of SMI ranges from 22% to 60% of the total MI incidence, and the prognosis of these SMIs has been shown to be similar to, or worse than, clinically recognized MI . However, the current understanding of the epidemiology of SMI is based primarily on studies in white populations of European ancestry, 8, [11] [12] [13] [14] [15] 18 or on studies with limited representation of both sexes. 9, 10, 16, 18, 21, 23 The lack of race and sex diversity in these studies is occasionally complicated by small sample size as well. 7, 28 The aim of this study was to examine the race and sex differences in the incidence and prognostic significance of SMI vs. MI with clinical manifestations (CMI) in the Atherosclerosis Risk in Communities (ARIC) study, a community-based predominantly biracial cohort study. clinical trials evaluating interventions to prevent or treat CHD, detection of unrec c cog og ogni ni nize ze zed d d MI MI MI a a as a clinical end point has the potential to increase statistical power and allowing decreased sample r ize es s s or or or r r red ed educ uc uced l l le en ength of follow-up, cost, and po po pote te tent n n ial harm from exp po pos s sure. 4 The repo po port r e ed d i i inc nc ncid id iden en ence ce ce o of f f SM SM SMI I I ra a ange e es from m 22% % % t to to 6 6 60% 0% 0% of f f th th the e e to to t tal MI MI MI i i inc nc ncid id iden en nce ce ce, , , an an and d d 
Methods

Study population
The ARIC study was designed to investigate the causes of atherosclerosis and its clinical outcomes, as well as variation in cardiovascular risk factors, medical care, and disease by race and sex. 29 After all exclusions (n=6,294), 9,498 remained and were included in the analysis.
were mostly white in the Washington County and Minneapolis sites, exclusively b b bla la lack ck ck i i in n n Jackson, and a mix of both in Forsyth County. The study was approved by each study site's nstit it tut ut utio io iona na nal l l re r r vi i iew ew ew board. All participants provid id ided ed ed written informed c co con n nsent.
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CHD death and all-cause mortality
CHD death and all-cause mortality were ascertained after ARIC visit 4 (1996-1998) through Baseline hypertension was defined as systolic blood pressure 140 mm Hg, diastolic blood pressure 90 mm Hg, or the use of blood pressure-lowering medications. At each study visit, medication history was obtained by self-report of medication intake during last 2 weeks and by reviewing medications brought by the participants to their visits. Each medication was coded by trained and certified interviewers with the use of a computerized medication classification enzymes and evolving ST-T pattern. Criteria for each of these diagnostic elements ts ts i i in n n th th the e e algorithm remained constant over the study period and are described in detail in the ARIC Study
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Statistical methods
Frequency distributions of the variables used in analyses were first inspected to rule out anomalies and outliers. Descriptive statistics were used to determine mean values, standard deviations, and percentile distributions for continuous variables, and frequencies and percentages for categorical variables.
During the period from visit 1 to visit 4, incidence rates of SMI and CMI were calculated 
Results
This analysis included 9,498 participants (age at baseline 54.0 (+ 5.7) years, 56.9% women, and 20.3% African American). From baseline through the 4 th ARIC visit, 317 participants developed SMI while 386 developed CMI. Table 1 shows the baseline characteristics of the study participants stratified by MI status. Table 2 shows the incidence rate (per 1000 person-years) of SMI and CMI, overall and stratified by sex and race. Overall, the incidence rate of CMI was slightly higher than SMI.
However, sex and race differences in the incidence of SMI and CMI were observed. The incidence rates of both SMI and CMI were higher in men compared to women (p-value <.0001).
On the other hand, blacks had non-significantly higher rate of SMI than whites (p-value= 0.217) but white had higher rate of CMI than blacks (p-value=0.002). Figure 1 shows the incidence rates of SMI and CMI in white men, black men, white women and black women. As shown, the incidence rate of SMI was higher than CMI in black women, which is the opposite of what is observed in white men in whom CMI was more common than SMI. On the other hand, the incidence rates of SMI were comparable to those of CMI in white women and black men. all-cause mortality, respectively) -free survival curves by MI status (no MI, SMI and CMI).
In multivariable adjusted Cox proportional hazards analysis, both SMI and CMI (compared to no MI) were associated with increased risk of CHD death ( Table 3 ) and all-cause mortality ( Table 4 ). However, SMI and CMI were associated with increased risk of mortality among both men and women, with potentially greater increased risk among women (interaction p-value=0.089 and 0.051, respectively). No significant interaction by race was detected.
Discussion
In this analysis from the ARIC study, one of the largest community-based biracial cohort studies in the US, we examined the sex and racial differences in the incidence and prognostic significance of silent vs. clinically-manifested MI. The three key findings are: 1) SMI is common; about 45% of the MIs are silent; 2) Both SMI and CMI are associated with poor prognosis with CMI showing slightly stronger association with risk of death than SMI; 3) There are race and sex differences in the incidence and prognostic significance of SMI. These findings highlights the importance of detection of SMI, and the potential impact of such detection on personalized prevention of CHD that takes into account race and sex. This is further underscored by the known sex and race disparity in CHD incidence and prognosis, 36 and the fact that those with SMI are deprived from medical attention compared to those with CMI.
Several previous studies have examined the prevalence, incidence and prognostic significance of SMI. In literature reviews by Pride et al, 4 and by Sheifer et al, 37 SMI constituted up to 44% of the total MIs, and carried a prognosis that was as poor as that for CMIs. The years and older, SMI accounted for 22% of the prevalent MIs. 19 In a similar cohort of elderly patients aged >75 years, the Bronx Aging Study, SMIs represented 44% of the total MIs. 17 On the other hand, in the Heart and Estrogen/progestin Replacement Study Trial, which included only women, SMI constituted only 4% of the total MI, 38 which is much lower than the Reykjavik Study in Women in which SMIs represented 33% of the total MIs. 10 Similarly, different studies showed different prognosis of SMI, with some reporting similar or poorer prognosis 17, 26 and others showing better prognosis with SMI compared to CMI. 7, 39 Differences in the incidence and prognostic significance among different studies could be explained by differences in the population studied (e.g. distribution of age, race and sex) and the method by which SMI is detected (e.g. Q wave in the ECG, myocardial scar in the cardiac magnetic resonance imaging, or areas of akinesia in the echocardiography). Even within studies that used ECG to define silent MI there are differences, some used serial Q/ST/T changes 26 and others used MI at each point of time as our study. Regardless of these differences, the overall incidence and prognostic significance of SMI in these studies generally accord with our results.
However, none of these studies had the large sample size or the ethnically diverse communitybased population with good representation of both sexes as our study. Hence, the race and sex differences in the incidence and prognostic significance of SMI were not appropriately examined in previous studies. Therefore, our results expand upon the previous studies and also extend our previous ARIC report on SMI that examined the incidence but not the prognostic significance of these MIs. 40 Our observations of the race and sex differences in the incidence and prognostic significance of SMI adds to the accumulating evidence of the sex and racial differences in CVD outcomes and the potential differences in the impact of risk factors among sexes and races. Because we adjusted for several potential confounders, it is less likely that our observed sex and racial differences were confounded by differences in MI-associated morbidities. Future investigation should assess whether genetic background, emerging risk factors, access to health care, awareness, and adherence to medications contribute to sex and racial differences.
Our results should be read in the context of certain limitations. Our analyses included only whites and blacks, and hence our results may not be generalizable to other races/ethnicities. Although we adjusted for several potential confounders in the models examining the association between SMI and CMI with outcomes, residual confounding remains a possibility as all similar studies. Q-waves often disappear after MI, and hence the SMI incidence in our study might be underestimated given the time between visits. Also, the increasing sensitivity of troponin in the past decade probably have yielded more CMI, and subsequently less SMI in the later stages of ARIC compared to before.
Although this should not impact the race and sex differences, it may impact the trend of SMI over time. Also, there were no significant changes in the sensitivity of troponin before 1998, the date our ascertainment of silent MI ended. Despite these limitations, our study was able to document the race and sex differences in the incidence and prognostic significance of SMI and compare the results to CMI in a large, well-designed prospective cohort study with long term follow-up; the ARIC study.
Other strengths include standardized ECG procedures and carefully documented outcomes events ascertained by an independent adjudication committee.
In conclusion, in the ARIC study we showed that SMI is as common as CMI; 45% of the MIs are silent, and that both SMI and CMI are associated with poor outcomes. However, there are race and sex differences in the incidence and prognostic significance of SMI. Thus, accidental ECG finding of MI in persons without a history of MI may warrant enhanced CHD prevention efforts that take into account sex and race differences.
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Clinical Perspective
This report from the Atherosclerosis Risk in Communities (ARIC) study, one of the largest community-based biracial cohort studies in the US, shows that presence of asymptomatic or silent myocardial infarction on screening electrocardiograms is a common finding; about 45% of the total number of myocardial infarctions in the study were silent. These silent myocardial infarctions were associated with increased risk of death in a magnitude that is relatively comparable to myocardial infarctions with clinical manifestations. However, race and sex differences in the incidence and prognostic significance of silent myocardial infarction were observed in this study. These findings highlights the importance of detection of silent myocardial infarctions, and the potential impact of such detection on personalized prevention of coronary heart disease that takes into account race and sex.
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